Orthofix Medical (OFIX) EBT (2010 - 2026)

Orthofix Medical has disclosed EBT across 17 years of filings, most recently posting -$20.8 million for Q1 2026.

• Quarterly EBT rose 60.04% year-over-year to -$20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.8 million (up 123.97% YoY) and the FY2025 annual result came in at $2.5 million, up 101.99% from the prior year.
• EBT fell to -$20.8 million in Q1 2026, from $91.1 million in the prior quarter.
• Over five years, EBT peaked at $132.7 million in Q4 2023 and troughed at -$60.3 million in Q1 2023.
• A 5-year average of -$9.0 million and a median of -$22.3 million in 2025 frame the typical range for EBT.
• Biggest YoY gain for EBT was 1999.89% in 2023; the steepest drop was 1346.48% in 2023.
• Tracing OFIX's EBT over 5 years: stood at -$7.0 million in 2022, then surged by 1999.89% to $132.7 million in 2023, then tumbled by 122.38% to -$29.7 million in 2024, then jumped by 406.57% to $91.1 million in 2025, then plunged by 122.87% to -$20.8 million in 2026.
• Business Quant data shows OFIX's EBT at -$20.8 million in Q1 2026, $91.1 million in Q4 2025, and -$22.3 million in Q3 2025.